BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2898351)

  • 1. The metabolism and disposition of fenofibrate in rat, guinea pig, and dog.
    Weil A; Caldwell J; Strolin-Benedetti M
    Drug Metab Dispos; 1988; 16(2):302-9. PubMed ID: 2898351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism and disposition of 14C-fenofibrate in human volunteers.
    Weil A; Caldwell J; Strolin-Benedetti M
    Drug Metab Dispos; 1990; 18(1):115-20. PubMed ID: 1970770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in the chirality of the carbonyl reduction of [14C] fenofibrate in laboratory animals and humans.
    Weil A; Caldwell J; Guichard JP; Picot G
    Chirality; 1989; 1(3):197-201. PubMed ID: 2642049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition and metabolism of fenbufen in several laboratory animals.
    Chiccarelli FS; Eisner HJ; Van Lear GE
    Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolism of fenofibrate and fenofibric acid in vivo and in cultures of liver epithelial cells (author's transl)].
    Dulery B; Hammami M; Chessebeuf M; Legendre M; Noly P; Padieu P; Maume BF
    Nouv Presse Med; 1980 Dec; 9(49):3729-32. PubMed ID: 7208338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of fenofibrate in man (author's transl)].
    Harvengt C; Desager JP
    Nouv Presse Med; 1980 Dec; 9(49):3725-7. PubMed ID: 7208337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer.
    Dawley RM; Zenser TV; Mattammal MB; Lakshmi VM; Hsu FF; Davis BB
    Cancer Res; 1991 Jan; 51(2):514-20. PubMed ID: 1898713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antilipidemic drugs. Part 4: The metabolic fate of the hypolipidemic agent isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-protionate (LF 178) in rats, dog and man.
    Brodie RR; Chasseaud LF; Elson FF; Franklin ER; Taylor T
    Arzneimittelforschung; 1976; 26(5):896-901. PubMed ID: 989365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and metabolism of timiperone in the rat, dog, and monkey.
    Tachizawa H; Sudo K; Sasano H; Sano M
    Drug Metab Dispos; 1981; 9(5):442-8. PubMed ID: 6117443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species differences in the metabolism of suprofen in laboratory animals and man.
    Mori Y; Kuroda N; Sakai Y; Yokoya F; Toyoshi K; Baba S
    Drug Metab Dispos; 1985; 13(2):239-45. PubMed ID: 2859175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic disposition of [14C]pivhydrazine, [14C]mebanazine, and [14C]benzylhydrazine in the rat.
    Bolton GC; Griffiths LA
    Drug Metab Dispos; 1979; 7(6):388-92. PubMed ID: 43225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
    Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
    Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW
    Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disposition of the hypolipidemic agent, o-(N-phthalimido)acetophenone, in Sprague-Dawley rats.
    Hall IH; Reynolds DJ; Wyrick SD; Maguire JH; Shrewsbury RP
    Drug Metab Dispos; 1988; 16(2):196-200. PubMed ID: 2898332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacology of fenofibrate (author's transl)].
    Kritchevsky D
    Nouv Presse Med; 1980 Dec; 9(49):3769-73. PubMed ID: 7208345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.
    Ando T; Momota K; Sugiyama M
    Arzneimittelforschung; 1986 Aug; 36(8):1221-8. PubMed ID: 3778559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.